INMUNE BIO, INC.

INMB NASDAQ
6.03
+0.02
+0.33%
休市 16:00 08/23 EDT
开盘
6.11
昨收
6.01
最高
6.11
最低
5.88
成交量
1.41万
成交均量(3M)
2.17万
52周最高
11.50
52周最低
5.06
换手率
0.13%
市值
6,489.77万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供INMUNE BIO, INC. INMB股票价格,INMUNE BIO, INC.股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Inmune Bio Inc. is a clinical-stage pharmaceutical immunotherapy company. The Company is focused on developing strategies for oncology that focus on re-engineering and harnessing the innate immune system to treat the patient’s cancer. The Company’s product candidates (INMB) target cells of the innate immune system that include natural killer cells (NK cells) and myeloid derived suppressor cells, (MDSC cells). The NK cell of the innate immune system has two primary functions, such as to kill virally infected cells and to kill cancer cells. Its INB03 is a protein biologic that has beneficial effects in patients with cancer. Its initial focus is on its ability to inhibit proliferation and function of myeloid-derived suppressor cells (MDSC).
展开 >

最近浏览

名称
价格
涨跌幅